INDIAN BENCHMARKS are likely to open on a cautious note as the global cues look mixed with SGX Nifty trading 12.50 points lower.
Headlines for the day:
Aurobindo Pharma receives USFDA approval for anti-epileptic drug
Biocon's arm Syngene International gets SEBI approval for IPO
TVS Srichakra extends gain on ties up with France's Michelin
Trend in FII flows: The FIIs were net sellers of Rs -604.86 Cr in the cash segment on Monday while the DIIs were net buyers of Rs 650.47 Cr, as per the provisional figures released by the NSE.
No comments:
Post a Comment